WBA - Walgreens Q4 Profit Annual Outlook Falls Short Of Expectations On Lower Demand For Covid Vaccines Tests | Benzinga
Walgreens Boots Alliance Inc's (NASDAQ: WBA) Q4 FY23 sales increased 9.2% Y/Y to $35.4 billion, up 8.3% on a constant currency basis, beating the consensus of $34.82 billion.
Adjusted operating income was $683 million, down 9.8% Y/Y, reflecting lower volumes of COVID-19 vaccinations and testing, partly offset by improvements in underlying U.S. pharmacy, lower incentive accruals, strong International growth, and improved profitability in U.S. Healthcare.
Adjusted EPS decreased 18% to $0.67, reflecting a 23.5% ...